FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005161721> ?p ?o ?g. }

• W3005161721 endingPage "1012" @default.
• W3005161721 startingPage "1005" @default.
• W3005161721 abstract "Permanent impairment (PI) of vital organs is one of the transplantation-related health problems affecting the quality of life and morbidity even in patients who do not develop graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HCT), but no data are available on PI of multiple organs. This retrospective study aimed to estimate a novel composite endpoint of PI-free, relapse-free survival (PIRFS) in 164 allo-HCT recipients. We defined PI as >26% to 30% impairment of the whole person in 6 vital organs using the whole person impairment rating. Conventional GVHD-free/relapse-free survival (GRFS) and PIRFS at 5 years were 33.8% (95% confidence interval [CI], 26.5% to 41.3%) and 40.6% (95% CI, 32.6% to 48.4%), respectively. In the whole cohort, PIRFS was higher than GRFS at any time after allo-HCT. However, PIRFS was lower than GRFS after day 397 post-transplantation in patients who underwent umbilical cord blood transplantation (UCBT). In UCBT recipients, 5-year GRFS and PIRFS were 47.6% (95% CI, 34.3% to 59.7%) and 39.2% (95% CI, 26.6% to 51.5%), respectively. The cumulative incidence of PI after 5 years was 20.9% (95% CI, 13.7% to 29.0%) in patients surviving for ≥6 months without relapse. The multivariate analysis revealed that high disease risk (hazard ratio [HR], 1.91; 95% CI, 1.26 to 2.88; P < .01) and Karnofsky Performance Status score ≤90% at transplantation (HR, 1.73; 95% CI, 1.14 to 2.63; P = .01) were correlated with the lower PIRFS, whereas UCBT (HR, 2.35; 95% CI, 1.11 to 4.99; P = .03), grade III-IV acute GVHD by day 180 (HR, 3.59; 95% CI, 1.04 to 12.4; P = .04), and thrombotic microangiopathy by day 180 (HR, 2.74; 95% CI, 1.10 to 6.87; P = .03) were significantly correlated with a higher incidence of PI. More than 20% of long-term survivors had PI. Our data suggest that PIRFS is a useful endpoint for assessing long-term transplantation success from a different perspective than has been established previously." @default.
• W3005161721 created "2020-02-14" @default.
• W3005161721 creator A5004483500 @default.
• W3005161721 creator A5008455044 @default.
• W3005161721 creator A5011178861 @default.
• W3005161721 creator A5047575606 @default.
• W3005161721 creator A5071962895 @default.
• W3005161721 creator A5074752282 @default.
• W3005161721 date "2020-05-01" @default.
• W3005161721 modified "2023-09-27" @default.
• W3005161721 title "Permanent Impairment-Free, Relapse-Free Survival: A Novel Composite Endpoint to Evaluate Long-Term Success in Allogeneic Transplantation" @default.
• W3005161721 cites W1751193725 @default.
• W3005161721 cites W1968047497 @default.
• W3005161721 cites W1974729843 @default.
• W3005161721 cites W1979578577 @default.
• W3005161721 cites W1988049454 @default.
• W3005161721 cites W1990497625 @default.
• W3005161721 cites W2005758735 @default.
• W3005161721 cites W2013430013 @default.
• W3005161721 cites W2015825671 @default.
• W3005161721 cites W2019111335 @default.
• W3005161721 cites W2020551482 @default.
• W3005161721 cites W2038400179 @default.
• W3005161721 cites W2038981426 @default.
• W3005161721 cites W2047158849 @default.
• W3005161721 cites W2049229230 @default.
• W3005161721 cites W2053419680 @default.
• W3005161721 cites W2062138135 @default.
• W3005161721 cites W2082637979 @default.
• W3005161721 cites W2106449858 @default.
• W3005161721 cites W2114959330 @default.
• W3005161721 cites W2121960517 @default.
• W3005161721 cites W2128812336 @default.
• W3005161721 cites W2128854969 @default.
• W3005161721 cites W2145632027 @default.
• W3005161721 cites W2152189242 @default.
• W3005161721 cites W2155460260 @default.
• W3005161721 cites W2167765664 @default.
• W3005161721 cites W2379365975 @default.
• W3005161721 cites W2535140827 @default.
• W3005161721 cites W2547498584 @default.
• W3005161721 cites W2569460261 @default.
• W3005161721 cites W2590553881 @default.
• W3005161721 cites W2605127543 @default.
• W3005161721 cites W2614067057 @default.
• W3005161721 cites W2746354396 @default.
• W3005161721 cites W2769339849 @default.
• W3005161721 cites W2788254623 @default.
• W3005161721 cites W2887792780 @default.
• W3005161721 cites W2900055535 @default.
• W3005161721 cites W2910771572 @default.
• W3005161721 cites W4230510991 @default.
• W3005161721 cites W4293241248 @default.
• W3005161721 cites W613454817 @default.
• W3005161721 doi "https://doi.org/10.1016/j.bbmt.2020.01.025" @default.
• W3005161721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32035276" @default.
• W3005161721 hasPublicationYear "2020" @default.
• W3005161721 type Work @default.
• W3005161721 sameAs 3005161721 @default.
• W3005161721 citedByCount "1" @default.
• W3005161721 countsByYear W30051617212022 @default.
• W3005161721 crossrefType "journal-article" @default.
• W3005161721 hasAuthorship W3005161721A5004483500 @default.
• W3005161721 hasAuthorship W3005161721A5008455044 @default.
• W3005161721 hasAuthorship W3005161721A5011178861 @default.
• W3005161721 hasAuthorship W3005161721A5047575606 @default.
• W3005161721 hasAuthorship W3005161721A5071962895 @default.
• W3005161721 hasAuthorship W3005161721A5074752282 @default.
• W3005161721 hasBestOaLocation W30051617211 @default.
• W3005161721 hasConcept C126322002 @default.
• W3005161721 hasConcept C141071460 @default.
• W3005161721 hasConcept C143998085 @default.
• W3005161721 hasConcept C167135981 @default.
• W3005161721 hasConcept C168563851 @default.
• W3005161721 hasConcept C203014093 @default.
• W3005161721 hasConcept C203092338 @default.
• W3005161721 hasConcept C207103383 @default.
• W3005161721 hasConcept C2776955114 @default.
• W3005161721 hasConcept C2777408962 @default.
• W3005161721 hasConcept C2911091166 @default.
• W3005161721 hasConcept C44249647 @default.
• W3005161721 hasConcept C50382708 @default.
• W3005161721 hasConcept C71924100 @default.
• W3005161721 hasConcept C72563966 @default.
• W3005161721 hasConcept C88879693 @default.
• W3005161721 hasConceptScore W3005161721C126322002 @default.
• W3005161721 hasConceptScore W3005161721C141071460 @default.
• W3005161721 hasConceptScore W3005161721C143998085 @default.
• W3005161721 hasConceptScore W3005161721C167135981 @default.
• W3005161721 hasConceptScore W3005161721C168563851 @default.
• W3005161721 hasConceptScore W3005161721C203014093 @default.
• W3005161721 hasConceptScore W3005161721C203092338 @default.
• W3005161721 hasConceptScore W3005161721C207103383 @default.
• W3005161721 hasConceptScore W3005161721C2776955114 @default.
• W3005161721 hasConceptScore W3005161721C2777408962 @default.
• W3005161721 hasConceptScore W3005161721C2911091166 @default.
• W3005161721 hasConceptScore W3005161721C44249647 @default.
• W3005161721 hasConceptScore W3005161721C50382708 @default.

• next